Additionally, increased expression of ZFAS1 was closely correlated with poorer overall survival in colorectal cancer, gastric cancer, glioma, osteosarcoma, oesophageal squamous cell carcinoma, ovarian cancer, and NSCLC. Here, ZFAS1 is linked to non-small cell lung carcinoma.